Senators Hatch and Harkin Express Support for Impending NDI Guidance
In particular, the letter expresses the senators’ expectations that the NDI guidance will be in line with the policies enacted by the Dietary Supplement Health and Education Act of 1994 (DHSEA).
A letter sent by Senators Tom Harkin (D-IA) and Orrin Hatch (R-UT) to FDA Commissioner Margaret Hamburg last week expresses support for FDA’s upcoming publication of new dietary ingredient (NDI) guidance, which the agency is due to deliver in July.
In particular, the letter expresses the senators’ expectations that the NDI guidance will be in line with the policies enacted by the Dietary Supplement Health and Education Act of 1994 (DHSEA).
“While the guidance should clarify when manufacturers must submit New Dietary Ingredient Notices, it should also refrain from erecting barriers that will inhibit or needlessly delay consumer access to safe products that were in fact marketed in the U.S. prior to October 15, 1994,” the letter states. “The intent of the law was to give FDA the tools necessary to help ensure the safety of dietary supplements and the accuracy of the limited claims allowed for them, but also to minimize regulatory burdens that might inhibit consumer access to lawfully manufactured and labeled supplement products.”
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.
